Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Forte Biosciences (FBRX) Accumulated Expenses (2016 - 2020)

Forte Biosciences (FBRX) has disclosed Accumulated Expenses for 5 consecutive years, with $898000.0 as the latest value for Q3 2020.

  • Quarterly Accumulated Expenses fell 41.15% to $898000.0 in Q3 2020 from the year-ago period, while the trailing twelve-month figure was $898000.0 through Sep 2020, down 41.15% year-over-year, with the annual reading at $175000.0 for FY2019, 93.84% down from the prior year.
  • Accumulated Expenses for Q3 2020 was $898000.0 at Forte Biosciences, up from $866000.0 in the prior quarter.
  • The five-year high for Accumulated Expenses was $11.2 million in Q2 2018, with the low at $34000.0 in Q1 2020.
  • Average Accumulated Expenses over 5 years is $2.2 million, with a median of $882000.0 recorded in 2020.
  • The sharpest move saw Accumulated Expenses crashed 98.58% in 2017, then skyrocketed 11336.73% in 2018.
  • Over 5 years, Accumulated Expenses stood at $5.4 million in 2016, then plummeted by 98.58% to $77000.0 in 2017, then skyrocketed by 3588.31% to $2.8 million in 2018, then crashed by 93.84% to $175000.0 in 2019, then surged by 413.14% to $898000.0 in 2020.
  • According to Business Quant data, Accumulated Expenses over the past three periods came in at $898000.0, $866000.0, and $34000.0 for Q3 2020, Q2 2020, and Q1 2020 respectively.